共 121 条
[1]
Hanks GE(2003)Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the radiation therapy oncology group protocol 92–02 J Clin Oncol 21 3972-3978
[2]
Pajak TF(2007)Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial Lancet Oncol 8 475-487
[3]
Porter A(2005)Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial JAMA 294 1233-1239
[4]
Grignon D(2007)Management of prostate cancer recurrences after radiation therapy-brachytherapy as a salvage option Cancer 110 1405-1416
[5]
Brereton H(2004)Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1-T3 prostate carcinoma in the prostate-specific antigen era: what should we expect? Cancer 100 1283-1292
[6]
Venkatesan V(2003)Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era Int J Radiat Oncol Biol Phys 57 915-928
[7]
Dearnaley DP(2007)Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature Cancer 110 1417-1428
[8]
Sydes MR(2005)Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer Clin Cancer Res 11 3353-3362
[9]
Graham JD(2008)Safety and immunologic response of a viral vaccine to prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an adjuvant Clin Cancer Res 14 5284-5291
[10]
Aird EG(2006)A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer Clin Cancer Res 12 1260-1269